TRACON Pharmaceuticals, Inc. (TCON)

TRACON Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	1.75	-3.59	-29.31	-28.73	-17.33	-22.66
Depreciation & Amortization	0.02	0.01	0.07	-0.06	-0.01	0.02
Share-Based Compensation	1.87	1.97	2.04	1.78	1.03	1.62
Other Operating Activities	2.5	5.28	0.96	4.44	-0.74	-2.63
Operating Cash Flow	6.14	3.68	-26.24	-22.57	-17.04	-23.65
Capital Expenditures	0	0	-0.02	-0.05	-0.01	0
Change in Investments	-	-	-	-4	-4	-23.98
Other Investing Activities	-	-	-	8	-	38
Investing Cash Flow	0	0	-0.02	3.95	-4	14.02
Common Stock Issued	5.61	7.96	7.88	13.36	38.16	2.29
Other Financing Activities	-10.46	-20.5	11.81	-2.8	-1.4	-1.39
Financing Cash Flow	-4.85	-12.54	19.68	10.56	36.76	0.91
Net Cash Flow	1.29	-8.87	-6.57	-8.06	15.72	-8.72
Free Cash Flow	6.14	3.68	-26.26	-22.62	-17.05	-23.65
Free Cash Flow Margin	50.52%	30.52%	-	-6537.28%	-	-
Free Cash Flow Per Share	2.57	0.11	-1.26	-1.31	-1.90	-7.79

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.